Home/Filings/4/0001209191-17-039915
4//SEC Filing

PUMA BIOTECHNOLOGY, INC. 4

Accession 0001209191-17-039915

$PBYICIK 0001401667operating

Filed

Jun 13, 8:00 PM ET

Accepted

Jun 14, 6:13 PM ET

Size

5.5 KB

Accession

0001209191-17-039915

Insider Transaction Report

Form 4
Period: 2017-06-12
ZAVRL FRANK
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-06-12+7,6047,604 total
    Exercise: $79.20Exp: 2027-06-11Common Stock (7,604 underlying)
Footnotes (1)
  • [F1]The option vests in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer.

Issuer

PUMA BIOTECHNOLOGY, INC.

CIK 0001401667

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001401667

Filing Metadata

Form type
4
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 6:13 PM ET
Size
5.5 KB